Hematology/Oncology

Top Story

Clinically diagnosed tumors linked to improvements in cancer-specific survival

May 6, 2016

A clinical diagnosis of early-stage lung cancer was associated with improvements in cancer-specific survival compared with only receiving a pathological diagnosis, according to results of a SEER analysis presented at the European Lung Cancer Conference.

Talha Shaikh, MD, radiation oncology resident at Fox Chase Cancer Center, and colleagues sought to examine trends in the use of clinical diagnosis and the effect on treatment outcomes in 7,050 patients receiving radiotherapy for early-stage lung cancer.

Meeting News Coverage

Hyperglycemia increases infection risk in older patients with AML

May 6, 2016
Hyperglycemia appears common in patients aged older than 65 years with acute myeloid leukemia and increased risk for infection, according to results of a retrospective…
In the Journals

Landmark prostate cancer screening trial may have misrepresented data

May 5, 2016
The rates of PSA screening reported in the control group of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial may have been inaccurately reported…

Henry Ford Health System program director named Komen Scholar

May 5, 2016
Lisa A. Newman, MD, MPH, director of the breast cancer program at Henry Ford Health System, has been selected to serve as a Komen Scholar for a 3-year term.Komen…
Meeting News Coverage

ABIM to offer new MOC assessment options in January 2018

May 5, 2016
The American Board of Internal Medicine plans to offer a new Maintenance of Certification examination option in January 2018, according to a press release issued by the…
More News Headlines »
CME

The Patient with Multiple Ecchymoses

No commercial support for this activity.

Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin…
More »
Video
At Issue

VIDEO: Progress in MRD testing poised to further improve patient outcomes in myeloma

May 3, 2016
More »
Featured
CME

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan morganatic-roan